What sp will be if 2nd refined study is positive, page-4

RAP has said next studies/trials in Australia will run for both pediatric and adults in next 4-6 months in parallel, this would be the second step in regaining market confidence, next 1 month would be the first step to provide a very detail analysis of what happened in last clinical trials to the market.

Then they will target pediatric clinical trials in US with different protocol and processes 6-8 months later. Despite all the talk about they needing to do a CR, from their recent financials they have enough cash on hand given the cash expenditure was $5.4M last year and $3.3M were on R&D, with $1.8M spent last quarter so their salary and administrator cost continues to be very low, and you would think they can claim tax refund for those R&D.